THC Tenet Healthcare

• None no insider bought on the open market
• $71.7M sold by 14 insiders outside a trading plan
• None no planned (10b5-1) sales

1. Insider
   Trade
   Value
   Traded, filed
2. J Robert Kerrey Director
   Sale
   $3.2M 12,010 shares at $263.72 72% of stake
   Traded Sep 14 Filed Sep 16
   ↗
3. Richard J Mark Director
   Sale
   $2.6M 10,000 shares at $263.42 29% of stake
   Traded Sep 10 Filed Sep 14
   ↗
4. Nadja West Director
   Sale
   $298K 1,152 shares at $258.80 4.6% of stake
   Traded Sep 2 Filed Sep 3
   ↗
5. Lisa Y Foo COO
   Sale
   $6.4M 24,000 shares at $266.32 75% of stake
   Traded Aug 31 Filed Sep 1
   ↗
6. Cecil D Haney Director
   Sale
   $361K 1,300 shares at $278.03 9.4% of stake
   Traded Aug 24 Filed Aug 26
   ↗
7. Saumya Sutaria CEO
   Sale
   $27.6M 100,000 shares at $276.36 19% of stake
   Traded Aug 24–25 Filed Aug 26
   ↗
8. Tammy Romo Director
   Sale
   $2M 7,422 shares at $263.03 21% of stake
   Traded Aug 6–7 Filed Aug 10
   ↗
9. Roy Blunt Director
   Sale
   $158K 600 shares at $262.68 12% of stake
   Traded Aug 5 Filed Aug 7
   ↗
10. Lisa Y Foo COO
    Sale
    $2.6M 10,000 shares at $258.03 24% of stake
    Traded Jul 29 Filed Jul 31
    ↗
11. Christopher S. Lynch Director
    Sale
    $934K 3,837 shares at $243.44 29% of stake
    Traded Jul 27 Filed Jul 28
    ↗
12. Paola M Arbour EVP, Chief Information Officer
    Sale
    $2.7M 10,878 shares at $243.90 37% of stake
    Traded Jul 27 Filed Jul 28
    ↗
13. James L Bierman Director
    Sale
    $1.2M 5,000 shares at $244.96 14% of stake
    Traded Jul 27 Filed Jul 28
    ↗
14. J Robert Kerrey Director
    Sale
    $984K 5,638 shares at $174.52 25% of stake
    Traded May 28 Filed May 29
    ↗
15. Nadja West Director
    Sale
    $532K 3,000 shares at $177.35 11% of stake
    Traded May 27 Filed May 28
    ↗
16. Paola M Arbour EVP, Chief Information Officer
    Sale
    $1.5M 6,500 shares at $238.43 18% of stake
    Traded Mar 11 Filed Mar 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 29 option exercises, 18 share withholdings for taxes, 8 sales back to the company, 5 stock grants, and 3 gifts.